💨

Understanding Chronic Obstructive Pulmonary Disease

Dec 20, 2024

COPD Overview

Introduction

  • Chronic Obstructive Pulmonary Disease (COPD) covers chronic bronchitis and emphysema.
  • Often a mixture of both conditions in patients.
  • Major contributor: Smoking.

Chronic Bronchitis

  • Presentation: Productive cough, dyspnea.
  • Physical Exam: Wheezing and ronchi due to airway obstruction from mucus.
  • Pathophysiology:
    • Inflammation in airways leading to excessive mucus and fibrosis.
    • Mucus production due to goblet cells and fibrosis makes this disease irreversible.
    • Bronchospasm due to inflammation.
    • Main issue: Difficulty in exhalation.

Emphysema

  • Presentation: Dyspnea, barrel chest, diminished breath sounds.
  • Pathophysiology:
    • Destruction of elastic tissue, leading to bronchial collapse and alveolar septal destruction.
    • Loss of elastic tissue causes airway and alveolar enlargement.
    • Main issue: Air trapping and hyperinflation.
    • Causes: Smoking and alpha-1 antitrypsin deficiency (affects lower lobes).

Complications of COPD

  • Pneumonia: Due to airway obstruction and bacterial colonization.
  • Respiratory Failure: Triggered by infections, non-compliance with medication.
    • Type II Respiratory Failure: Elevated CO2, low oxygen.
  • Pulmonary Hypertension & Right Heart Failure: Due to chronic hypoxemia.
  • Polycythemia: Increased red blood cells due to low oxygen triggering erythropoietin.

Diagnosis of COPD

  • Clinical Features: Dyspnea, productive cough, wheezing, decreased breath sounds.
  • Tests: Chest x-ray, ECG, ABG, PFTs.
    • PFTs: FEV1/FVC ratio less than 70% indicates obstruction, low DLCO in emphysema.
  • Differentiation:
    • Emphysema affects upper lobes (smoking) vs. lower lobes (alpha-1 antitrypsin deficiency).

Treatment Strategies

  • Smoking Cessation
  • Vaccinations: Flu and pneumococcal.
  • Oxygen Therapy: For hypoxemia and preventing right heart failure, target O2 saturation 88-92%.

Medications

  • Mild COPD: SAMA or SABA for symptoms.
  • Moderate COPD: Add LABA to SAMA/SABA.
  • Severe COPD: Lama-Laba combination, and possibly inhaled corticosteroids.
  • Refractory Cases: Consider PDE4 inhibitors and possibly lung reduction surgery.

Acute Exacerbation

  • Bronchodilation: SAMA and SABA (Duoneb).
  • Systemic Steroids: Reduce inflammation.
  • BiPAP: Stents airways open, improves ventilation.
  • Antibiotics: Azithromycin or doxycycline for bacterial overgrowth.

Conclusion

  • Understanding and managing COPD involves recognizing symptoms, complications, and employing targeted treatments to improve patient outcomes.